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1794-1 ] lschemiaandlnfa~~tiOn COnt~ibutetoRi~ht
Ventricular Dysfunction Noted 10 to 20 Years After
the Muaterd Operation for Transposition of the Great
Arteries
T. Millane, E.J. Bernard, R.B. Howman-Giles, R.F. Uren, T.B.Cartmill,
R.E. Hawker, D.S. Celermajer. Roya4Alexandrs Hospital for C/ri/drenand
Royal Prince Alfred Hospital, Sydney NSW, Australia
Rightventricular dysfunction is an important cause of morbidity and mor-
tality after intra-atrial baffle repair for transposition of the great atteries (TGA).
The role of ischemia or infarction in the pathogenesis of RV dysfunction is
not known.
We used Tc-99m Sestamibi myocardial single photon emission computed
tomography (triple head gamma camera), with and without dipyridamole
infusion, to assess RV myocardial perfusion, wall thickening, wall motion and
ejection fraction in thirteen adolescence/young adults who had undergone
atrial baffle repair for simple TGA at median 6 (range 3-30) months of age.
At the time of the study, the subjects were aged 10-21 (mean 13.5) years; 11
were in NYHA class 1,and 2 in class Il. All were in a regular cardiac rhythm
during the studies (sinus in 11, nodal in 1, atrial flutter with 3:1 block in 1).
During dipyridamole stress, perfusion defects were present in all patients, in
a total of 27/106 (25%) of cardiac segments analysed; these defects were
fixed in 5 pts and fully reversible in 2, with a mixed picture in 6. Although RV
wall thickening at rest was abnormal in all pts, wall motion was abnormal at
rest in only 6, being completely normal in the two patients with fully reversible
perfuaion defects. Wall motion and wall thickening abnormalities generally
occurred in the same segments aa the observed patfusion defects. Median
RV ejection fraction was 50% (range 15+68).
8egmental perfusion defects and concordant regional wall motion abnor-
malities are mmmon in the right (systemic) ventricle ten to twenty years
after Mustard repair for TGA, even in asymptomatic patients. Ischemia or
infarction may therefore be important in the pathogenesis of RV dysfunction
in this group.
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PI ManagementandOut.omeaof ~i,htAtria,
leomerism-26 Year Experience
A. Hashmi, R. Abu-Sulaiman, J.F. Smallhom, W.G. Williams, R.M. Freedom,
B.W. McCrindle. TheHospital for Sick Children, Toronto, Ontario, Canada
To determine outcomes in patients with right atrial isomerism (RAI), we re-
viewed the clinical course of 73 consecutive patients (63% males) treated
at our institution from 1970-1996. The majority of patients presented at
birth (62%), with 67% presenting in the firat month of life. Cardiac abnor-
malities included anomalous pulmona~ venous (PVein) drainage in 66%,
PVein obstruction in 28Y0, pulmonary outflow tract obstruction in 68Y0,ven-
tricular hypoplasia or single ventricle in 74%, common AV valve in 78%,
and abnormal arterial connections in 97%. Overall mortality was 60%. No
interventions were performed in 15%, 82Y0 of whom died. The remaining
patients have survived to have the following procedures: Blalock-Taussig
ahunt, 43%; other systemic shunt, 18%; pulmonary artery band, 10%; PVein
repair, 29%; cave-pulmonary anastomosis, 21%; Fontan connection, 18’Z.
and heart transplantation in 2 patients. Kaplan Meier survival was 88”/0at
age 7 daya, 77% at 1 mo, 57% at 1yr, 44% at 5 yrs, 42% at 10Yrsand 33V0 at
20 yre. Survival in the last 10 yrs was significantly lower (p= 0.05) with 51°A
surviving to age 1 yr and 26%.to 5 yre. Risk factors for death included PVein
obstruction (Qdda Ratio [OR] 2.24, p = 0.0001), prostaglandin dependence
at presentation (OR 3.46, p = 0.0004), lower birth weight (OR 1.45 per 0.5
kg reduction, p = 0.01), and later date of presentation (1.39 per consecutive
5 year period, p =0.005). CorrclusiomRAI is associated with significant mor-
tality despite recent surgical innovations. Management of PVein obstruction
remains a serious problem and is associated with a poor outcome.
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1794-31smallventric~,ar*Pta, ~efec~sinAdu,~a
U. Neumayer, J. Somerville. Grown-Up Congenital Heart (GUCH) Unit,
Roya/ Brompton Hoapital, London, UK
166 adult patients (pta.) aged 17-72 (m = 29.2) yrs., 101 female, 87 male,
who had smail ventricular septai defect (VSD), size <1 cm defined by echo-
cardiography, Qp:Qs 2:1 or less and pulmonary attery pressure <40 mmHg
systolic, seen and registered on the GUCH database were studied. 138 pie.
were examined 1994/95. Pts. were excluded with inadequate data, valve
atresia, atrioventricular defects, double inlet or outlet ventricle, transposition,
maiposition, straddling valves, surgical or spontaneous closure of VSD be-
fore age 16 yrs. 50 pts, (26.6%) had additional cardiovascular lesions, most
commonly bicuspid aortic valve (16) ancf/or coarctation (15). Spontaneous
closure occurred in 19 (10%) age 17-45 (m = 27) yrs. Infective endocarditis
occurred in 21 (11.2%) without deaths, 5 patients had 2 attacks; 7 had opera-
tion. Aortic regurgitation developed in 37 pts., 12 with congenitally abnormal
and 25 with once normal tricuspid aortic valve, severe in 9. Atrial arrhythmias
occurred in 11 pts., supraventricular tachycardia in 4 (aged 25-42 yrs.) and
atrial fibrillation in 7 (aged 32-69 yrs.). In 4 pts. the onset of atrial fibrillation
produced severe congestion with features of “restrictive cardiomyopathy”
and exaggerated left ventricular to right atrial shunt looking like gross trf-
cuspid regurgitation. 2 pts. developed ventricular tachycerdia aged 25 and
45 yrs., both with infundibular defects and one with pulmonay regurgitation.
29 pts. had left ventricular enlargement on echocardiogram and/or chest
radiography with no obvious lesion to account for it; 11 had functional mitral
regurgitation; in 2 the defect had closed spontaneously,
Although 89 pts, (47%) aged 1744 (m = 26.8) yrs. had no complications
and normal investigations and there was a possibility (10%) of spontaneous
closure duringadulthood, 47(25%) of pts, > 16yrs. had serious complication
(infective endocarditis, severe aoflic re9ur9itation, symptomatic arrhythmia,
frank heart failure). We conclude that the course of small VSD is not entirely
benign.
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~] OneThoueandPatients~ith Adu,tCongenitS, fieart
Diaeaee: Causes of Death and Lessons Learned
H.M, Connolly, N.M. Ammaeh, C.A. Warnes. Mayo Medica/ Cenfe~
Rocheste< Minnesota, USA
One thousand patients (pts) were seen for evaluation in our adult congenital
heart disease clinic between 1987 and 1995, 53 (0.5%) have died during
follow-up. Causes of death were reviewed to identify etiology. and to de-
termine preventability. The primaty cardiac diagnosis of the 53 dead pts
includes: 12 Eisenmenger, 7 tetralogy of Fallot (TOF), 6 Ebstein’s, 5 single
ventricle, 5 pulmonary atresia, 4 d- and 4 i-transposition, 3 tricuspid atresia,
2 ventricular septal defect, 2 truncus arteriosus, and 1 each with pulmonary
stenosis, aorfic stenosis, and primum atrial septal defect. There were 27 men
and 26 women, age at death ranged from 18-70 yrs (mean 40.6 + 14 yrs)..
Four of the deaths (3 Eisenmenger, 1 TOF) occurred in Down’s pts, mean
age 26& 4.3 yrs.
Twenty deaths occurred following congenital cardiac surgery: (8 after
initial operation, 12 after raoperation), 3 due to preop endocarditis, 9 due to
advanced cardiac disease at referral, 5 due to suboptimal selection, and 3
due to unexpected surgical complications, Of the remaining 33 deaths; 17
were expected (9 Eisenmenger, 6 advanced cardiac disease), 7 were due
to heart failure, 6 were sudden and unexpected, 2 Eisenmenger pts died
following noncerdiac surge~, and 1 pt died from cancer,
Ten deaths were considered avoidable, these included: 3 sudden deatha
in pts with conduit obstruction (RV systolic pressure s 65% systemic), 2
deaths following non-cardiac surgety, 3 due to suboptimal surgical eelection,
and 2 due to unexpected surgical complications.
Conclusions: Inthis Iargeadult congenital referral population, most deaths
are due to unavoidable progressive cardiac disease, but important avoidable
causes of death still occur. This underscores the importance of: 1) earlier
recognition and referral of pts to tertiary centers, 2) special care of Eisen-
menger pts during non-cardiac surgery, 3) earlier intervention in pts with
conduit obstruction, and 4) refinement of surgical selection in pta with pul-
monafy atresia.
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n continuouainfusionof~ros~cyc,in,mproves
Piasma Markers of Endotheiial Cell injury in Primary
R. Friedman, J.G, Mears, R.J. Barst. Co/umbia University Co//ege of
Physicians and Surgeons, New York,NY, USA
Primary puimonaty hypertension (PPH) is a severe diaeaae, characterized
by vaecular injury of small puimona~ arteries and arteriole, in which en-
dothelial dysfunction may play a major role. Although previous studies have
demonstrated that continuous infusion of prostacyclin (PGIz) improves the
clinical status and survival of these patients, the mechanism(s) by which this
therapy works remains unclear. The objective of this study was to evaluate
the effects of chronic PGIz on clotting factors and platelet function in PPH.
Thidy-eight children and 26 adults with PPH were studied before prostacy-
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clin therapy and 22 children and 13 adults had repeat studies after 1 year
of chronic PG12.At baseline, 79% of the children and 87% of the adults had
abnormal platelet function. In addition, Factor Vlll, von Willebrand antigen
and ristocetin cofactor levels were abnormally high in 29%, 16% and 16%,
respectively, in the children, and in 92%, 72?. and 52Y0,respectively, in the
adults. On chronic PGIz therapy, platelet function normalized in 80% of the
children and in 83% of the adults who had platelet dysfunction at twseline(p< 0.01). Factor Vlll, von Willebrand antigen and ristocetin cofactor also
decreased on chronic prostacyclin in both the children and adults (p < 0.02).
In addition, the ratio of ristocetin cofactor to VW antigen, which may reflect
biological activity of VW Factor, increased on chronic PGIz in the adults from
an abnormally low level (0.56 * 0.22) to normal (1.12 & 0.42), and in the
children the ratio increased from 0.83 * 0.30to 1.26 *0.38 (normal 0.6-1.4).
In conclusion, these alterations in the coagulation system may contribute to
the pathogenesis of PPH and the normalization of these endotheiial markers
on chronic PG12therapy suggests that long-term prostacyclin remodels the
pulmonary vascular bed with subsequent decrease in endothelial cell injury.
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m Modeof DeathinAdultewithCongenitalHeart
— Diaeaae
E.N. Oechslin, D.A. Harrison, M.S. Connelly, C3.D.Webb, S.C. Siu. The
TorontoHospital, Toronto, ON, Canada
The cause of death in adults with congenital heart disease (CHD) has not
been well defined. We reviewed the outcomes of patients (pts) followed by
the Toronto Congenital Cardiac Centre for Adults (TCCCFA)during the years
1961-1996. Mortality and mechanism of death were obtained from health
records, next of kin, family physicians and the provincial death registry.
Pts transferred from out of province or directly referred for surgery were
not included. Simple anatomy was defined as atrial or ventricular septel
defect, patent ductus arIeriosus, bicuspid aortic valve, coarctation of the
aorta or primary pulmonary hypertension. All other defects were classified as
complex. Sudden death wae defined as death within one hour of previously
stable condition.
Ffesu/ts:Of the 2532 ptsseen during the study period at TCCCFA, 150 pts
(65 females, 85 males) are known to have died at average age 36.2• 14.0
yre. 59 of the deceased pts (39%) had a simple defect, 91 (61%) a complex
lesion. 41 pts have not had cardiac surgery.
33 deaths (22%) occurred intra- and postoperatively related to cardiac
eurgety. 36 pts (25%) had sudden deaths (92~o attributed to arrhythmia). 30
pts (20%) died due to heart failure: 8 (4%) arrhythmia non-sudden, 8 (5%) of
endocerditis, 11 other cardiac (7Yo)and 24 (18%) non-cardiac.
Conclusion.’The 3 major causes of death in adults with CHD are sudden,
peri-operative and heart failure. Reduction of mortality for this population will
require identification of risk factors for these complications.
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n7951 Gender-relatedlfferenceainatherosclerosis:Role
ofendothelin-1in proliferationofvaacularsmooth
musclecells
D.M. Antoniucci, V.M. Miller, L.A. Fitzpatrick. Departments ofhfedicine and
Surgery Mayo Clinic and Mayo Foundation, Rochestec MN, USA
Proliferation of vascular smooth muscle cells (VSMC) has been implicated in
thepathogenesis ofcoronefyarlery disease. Theincidence of atherosclerosis
varies greatly among men, postmenopausal women, and estrogen-replete
women. However, the mechanism by which sex steroid hormones leads
to differences in the expression of gender-related coronary artery disease
has not been mmpletely elucidated. Vascular smooth muscle cells contain
ETA receptors for endothelin-1 (ET-l), and receptors for estradiol and dihy-
drotestoeterone. Restudied theeffecfof ET-I on the proliferation of coronary
vascular smooth muscle cells obtained from sexually mature, gonadally intact
female and male pigs. VSMC were iedated via explant and growth-arrested
in serum-free, phenol red-free media, Effectore (ET-1, p-estradiol, (pE2), or
vehicle) were added (10-10-106 M) for 24 hours and proliferation assessed
bythymidine incorporation. In VSMCSobtained from sexually mature female
animals, ET-1 significantly inhibited coronary VSMC proliferation (p <0.005
by ANOVA). When ET-1 and A4EZwere added, the inhibition was greater
than with @E2alone. In contrast, ET-1 did not affect mitogenesis in coronary
VSMCSderived from sexually mature male animals. A significant difference
(p <0,001 by ANOVA) was noted in the response to ET-1 in male versus
female cells. VSMC were isolated from female animala that were oophorec-
tomized. ET-1 had no effect on proliferation of VSMC derived from this
estrogen-deplete environment. We conclude that the cardioprotective effect
of estradiol includes inhibition of VSMC proliferation by endothelin; this effect
is lost in male and estrogen-deplete (oophorectomized) female animals.
2:15
1795+1AcuteAdmini~trationof~Pecifi~~ndothe,in-A
ReceptorAntagonist,Attenuates
Endothelin-inducedbutnotAcetyicholine-lnduoed
CoronaryVasoconstrictionin Experimental
Hypercholeaterolemia
D, Hasdai, C.R. Cannan, V, Mathew, R.S. Schwartz, D,R. Holmes, Jr.,
A. Lerman. The Mayo Clinic, Roc/resteL A4JV,USA
Endothelin (ET) may participate in the coronary vasoconstriction associated
with endothelial dysfunction, This study was to designed to teet whether
acute administration of FR-139317, an ETA-receptor antagonist, attenuates
thecorona~ vasoconstrictor response to acetyicholine (Ach) in experimental
hypercholesterolemia (HC). The percent change in coronary artery diameter
(% ACAD) to intracoronarY infusions of eitherET-1 (5 rig/kg rein) or Ach
(lO-eMto 10-4M), each with co-infusion of either intracoronary normal saline
or FR-139317 (5 @kg minute), were meaeured by quantitative coronary
angiography in pigs. The studies were repeated after 10 weeks of high-
cholesterol diet. At 10 weeks there was a significant increase in plasma
cholesterol and circulating ET. FR-139317 alone did not affect systemic or
corona~ hemodynamics.
“AACAD ET(n = 5) ET+ FR(n= 6) Ach(n = 7) Ach+ FR(n= 6)
Bsseline –IS*8 –12+6 5*2 7*3
10wks.HC –77* 14” –14& 6t –23+ 12* –19* 7“
*p <0.05 Bassvs.HC,tp <0.05 FRvs.normalsaline.
We conclude that acute intracoronary administration of FR-139317 in
HC attenuates the anhanced epicardial coronary vasoconstricfor effects of
exogenously administered ET. However, FR-139317 at this dose dose not
attenuate Ach-induced coronaw vasoconstriction. Thus, tha ETA receptor
may not mediate Ach-induced coronary epicardial vasoconstriction in HC.
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1795-3]sulfonYlureasA~enuate~oronaWvasodi,atoW
Responsesto Adenosineandthe Dagreeof
AttenuationISIncreasedby EndothelialDysfunction
C.A. Davis Ill, A.J. Sherman, K.R. Hartis, S. Hedjbeli, Y. Yaroshenko,
F.J. Klocke. Feinberg Cardiovascular Research Institute, N6rthwestem
Univerai~, Chicago, IL, USA
Glyburide, a commonly used sulfonykrrea, is known to block ATPdependent
potassium channels, which play an important role in coronary vasodilatory
responses. These responses also depend on endothelial-derived factors,
particularly nitric oxide. Accordingly, we have studied the effects of glyburide,
with and without concomitant blockade of nitric oxide synthesis, on responses
of coronary flow to graded intracoronary infusion of adenosine (l&1,000
@rein) in seven chronically instrumented dogs. The EDm of dose-response
cuwes relating coronary conductance to adenosine concentration wae unaf-
fected by eystemic administration of 0.3 mg/kg glyburide (0.93 * 0.31 [SEM]
vs. 1.35 * 0.56 @ml, NS). ED50 increased systematically, however, foi-
Iowing 1.0 mg/kg glyburide (3.53 + 1.09 #@ml, p <0.05 ANOVA). When
nitric oxide synthesis was blocked (L-NAME, 1 mgJkgIV), glyburide-induced
reductions in adenosine responsiveness were augmented. The absolute in-
crease in ED50in reeponse to 0.3 mg/kg glyburide rose from 0.42 ~ 0.29 to
1.62 * 0.93 @ml (p -=0.05), and following 1.0 mg/kgglyburidefrom2.60
+ 0.99 to 13.0 * 6.47 #@ml (also p < 0.05). We conclude that sulfonylurea
therapy can attenuate coronary vasodilatoy responsesto adenosine,and
that the degreeof attenuationis augmentedin the preeenceof endothelial
dysfunction.
